QUICKLINKS AND VIEW OPITONS
Belviq (lorcaserin) causes weight loss of 3 to 3.7% more than placebo
Wednesday, June 27, 2012 10:50 am Email this article
Studies of the new weight loss drug Belviq (lorcaserin) for up to one year showed that increased weight loss by (only) 3 to 3.7 percent more than placebo. The drug was approved by the U.S. Food and Drug Administration today, June 27, 2012.
Fda. Fda approves belviq [lorcaserin hydrochloride] to treat some overweight or obese adults. FDA News Press Release. 2012 Jun 27,
Articles on the same subject can be found here:
Please feel free to share your comments about this article.
© Copyright 2003-2021 - Larry Hobbs - All Rights Reserved.